Cargando…
Analytic Morphomics in Myositis-Related Interstitial Lung Disease
PURPOSE: Interstitial lung disease (ILD) is the most common non-musculoskeletal manifestation of idiopathic inflammatory myopathies (IIM). Identification of body composition change may enable early intervention to improve prognosis. We investigated muscle quantity and quality derived from cross-sect...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444650/ https://www.ncbi.nlm.nih.gov/pubmed/37458801 http://dx.doi.org/10.1007/s00408-023-00637-3 |
_version_ | 1785093995503812608 |
---|---|
author | O’Mahony, Alexander T. Henry, Patrick J. Coghlan, Patrick Waldron, Michael Crowley, Claire Ryan, David Moore, Niamh Bennett, Deirdre M. O’Connor, Owen J. Maher, Michael M. Henry, Michael T. |
author_facet | O’Mahony, Alexander T. Henry, Patrick J. Coghlan, Patrick Waldron, Michael Crowley, Claire Ryan, David Moore, Niamh Bennett, Deirdre M. O’Connor, Owen J. Maher, Michael M. Henry, Michael T. |
author_sort | O’Mahony, Alexander T. |
collection | PubMed |
description | PURPOSE: Interstitial lung disease (ILD) is the most common non-musculoskeletal manifestation of idiopathic inflammatory myopathies (IIM). Identification of body composition change may enable early intervention to improve prognosis. We investigated muscle quantity and quality derived from cross-sectional imaging in IIM, and its relationship to ILD severity. METHODS: A retrospective cohort study assessing IIM of ILD patients (n = 31) was conducted. Two datasets separated in time were collected, containing demographics, biochemical data, pulmonary function testing and thoracic CT data. Morphomic analysis of muscle quantity (cross-sectional area) and quality (density in Hounsfield Units) on thoracic CT were analysed utilising a web-based tool allowing segmentation of muscle and fat. Bilateral erector spinae and pectoralis muscle (ESM&PM) were measured at defined vertebral levels. RESULTS: FVC and D(L)CO decreased but within acceptable limits of treatment response (FVC: 83.7–78.7%, p < 0.05, D(L)CO 63.4–60.6%, p < 0.05). The cross-sectional area of the PM and ESM increased (PM: 39.8 to 40.7 cm(2), p = 0.491; ESM: 35.2 to 39.5 cm(2), p = 0.098). Density significantly fell for both the PM and ESM (PM: 35.3–31 HU, p < 0.05; ESM: 38–33.7, p < 0.05). Subcutaneous fat area increased from 103.9 to 136.1 cm(2) (p < 0.05), while the visceral fat area increased but not reaching statistical significance. The change in PM density between time points demonstrated an inverse correlation with D(L)CO (p < 0.05, R = − 0.49). CONCLUSION: Patients with IIM ILD demonstrated significant body composition changes on CT imaging unlikely to be detected by traditional measurement tools. An increase in muscle area with an inverse decrease in density suggests poor muscle quality. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00408-023-00637-3. |
format | Online Article Text |
id | pubmed-10444650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-104446502023-08-24 Analytic Morphomics in Myositis-Related Interstitial Lung Disease O’Mahony, Alexander T. Henry, Patrick J. Coghlan, Patrick Waldron, Michael Crowley, Claire Ryan, David Moore, Niamh Bennett, Deirdre M. O’Connor, Owen J. Maher, Michael M. Henry, Michael T. Lung Interstitial Lung Disease PURPOSE: Interstitial lung disease (ILD) is the most common non-musculoskeletal manifestation of idiopathic inflammatory myopathies (IIM). Identification of body composition change may enable early intervention to improve prognosis. We investigated muscle quantity and quality derived from cross-sectional imaging in IIM, and its relationship to ILD severity. METHODS: A retrospective cohort study assessing IIM of ILD patients (n = 31) was conducted. Two datasets separated in time were collected, containing demographics, biochemical data, pulmonary function testing and thoracic CT data. Morphomic analysis of muscle quantity (cross-sectional area) and quality (density in Hounsfield Units) on thoracic CT were analysed utilising a web-based tool allowing segmentation of muscle and fat. Bilateral erector spinae and pectoralis muscle (ESM&PM) were measured at defined vertebral levels. RESULTS: FVC and D(L)CO decreased but within acceptable limits of treatment response (FVC: 83.7–78.7%, p < 0.05, D(L)CO 63.4–60.6%, p < 0.05). The cross-sectional area of the PM and ESM increased (PM: 39.8 to 40.7 cm(2), p = 0.491; ESM: 35.2 to 39.5 cm(2), p = 0.098). Density significantly fell for both the PM and ESM (PM: 35.3–31 HU, p < 0.05; ESM: 38–33.7, p < 0.05). Subcutaneous fat area increased from 103.9 to 136.1 cm(2) (p < 0.05), while the visceral fat area increased but not reaching statistical significance. The change in PM density between time points demonstrated an inverse correlation with D(L)CO (p < 0.05, R = − 0.49). CONCLUSION: Patients with IIM ILD demonstrated significant body composition changes on CT imaging unlikely to be detected by traditional measurement tools. An increase in muscle area with an inverse decrease in density suggests poor muscle quality. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00408-023-00637-3. Springer US 2023-07-17 2023 /pmc/articles/PMC10444650/ /pubmed/37458801 http://dx.doi.org/10.1007/s00408-023-00637-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Interstitial Lung Disease O’Mahony, Alexander T. Henry, Patrick J. Coghlan, Patrick Waldron, Michael Crowley, Claire Ryan, David Moore, Niamh Bennett, Deirdre M. O’Connor, Owen J. Maher, Michael M. Henry, Michael T. Analytic Morphomics in Myositis-Related Interstitial Lung Disease |
title | Analytic Morphomics in Myositis-Related Interstitial Lung Disease |
title_full | Analytic Morphomics in Myositis-Related Interstitial Lung Disease |
title_fullStr | Analytic Morphomics in Myositis-Related Interstitial Lung Disease |
title_full_unstemmed | Analytic Morphomics in Myositis-Related Interstitial Lung Disease |
title_short | Analytic Morphomics in Myositis-Related Interstitial Lung Disease |
title_sort | analytic morphomics in myositis-related interstitial lung disease |
topic | Interstitial Lung Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444650/ https://www.ncbi.nlm.nih.gov/pubmed/37458801 http://dx.doi.org/10.1007/s00408-023-00637-3 |
work_keys_str_mv | AT omahonyalexandert analyticmorphomicsinmyositisrelatedinterstitiallungdisease AT henrypatrickj analyticmorphomicsinmyositisrelatedinterstitiallungdisease AT coghlanpatrick analyticmorphomicsinmyositisrelatedinterstitiallungdisease AT waldronmichael analyticmorphomicsinmyositisrelatedinterstitiallungdisease AT crowleyclaire analyticmorphomicsinmyositisrelatedinterstitiallungdisease AT ryandavid analyticmorphomicsinmyositisrelatedinterstitiallungdisease AT mooreniamh analyticmorphomicsinmyositisrelatedinterstitiallungdisease AT bennettdeirdrem analyticmorphomicsinmyositisrelatedinterstitiallungdisease AT oconnorowenj analyticmorphomicsinmyositisrelatedinterstitiallungdisease AT mahermichaelm analyticmorphomicsinmyositisrelatedinterstitiallungdisease AT henrymichaelt analyticmorphomicsinmyositisrelatedinterstitiallungdisease |